Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncocyte Corp
(NQ:
OCX
)
2.860
+0.020 (+0.70%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,950
Open
2.810
Bid (Size)
2.850 (4)
Ask (Size)
2.910 (5)
Prev. Close
2.840
Today's Range
2.725 - 2.910
52wk Range
2.285 - 4.340
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OCX Stock Earnings: OncoCyte Beats EPS, Misses Revenue for Q2 2024
August 08, 2024
OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
Performance
YTD
-13.33%
-13.33%
1 Month
-6.84%
-6.84%
3 Month
-8.33%
-8.33%
6 Month
-1.04%
-1.04%
1 Year
+6.00%
+6.00%
More News
Read More
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
News Direct
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
TheNewswire.com
4 Analysts Assess OncoCyte: What You Need To Know
May 16, 2024
Via
Benzinga
OncoCyte's Earnings: A Preview
November 08, 2023
Via
Benzinga
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
September 18, 2023
Via
ACCESSWIRE
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
Via
ACCESSWIRE
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Via
InvestorPlace
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Via
MarketBeat
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
Via
InvestorPlace
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
August 28, 2023
Via
ACCESSWIRE
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Via
Benzinga
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
April 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
OCX Stock Earnings: OncoCyte Misses EPS, Misses Revenue for Q4 2023
April 12, 2024
Via
InvestorPlace
Top 3 Health Care Stocks That May Collapse In Q2
April 12, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 12, 2024
Via
InvestorPlace
Earnings Scheduled For April 12, 2024
April 12, 2024
Via
Benzinga
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
April 12, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 09, 2023
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 09, 2023
Via
Benzinga
Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 25, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.